Benzinga | Aug 5, 2020 07:50AM EDT

Ionis Pharmaceuticals Q2 EPS $(0.23) Beats $(0.27) Estimate, Sales $146.00M Miss $148.87M Estimate

Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.27) by 14.81 percent. This is a 2200 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $146.00 million which missed the analyst consensus estimate of $148.87 million by 1.93 percent. This is a 10.98 percent decrease over sales of $164.00 million the same period last year.